Searched over 200M research papers
8 papers analyzed
These studies suggest that high LDL cholesterol is associated with an increased risk of cardiovascular disease and can be managed through dietary changes, medications, and lifestyle interventions.
20 papers analyzed
Low-density lipoprotein (LDL) cholesterol is a critical factor in cardiovascular health. Elevated levels of LDL cholesterol are strongly associated with an increased risk of cardiovascular disease (CVD) . LDL cholesterol is often referred to as "bad cholesterol" because it can lead to the buildup of plaques in arteries, which can cause atherosclerosis and increase the risk of heart attacks and strokes.
Diet plays a significant role in managing LDL cholesterol levels. Reducing the intake of saturated fats, trans fats, and dietary cholesterol can help lower circulating LDL cholesterol. A meta-regression analysis has shown that increasing dietary cholesterol intake is positively associated with higher LDL cholesterol levels. For instance, an increase of 100 mg of dietary cholesterol per day can raise LDL cholesterol by approximately 1.90 to 4.58 mg/dL, depending on the model used.
Familial hypercholesterolemia (FH) is a genetic disorder characterized by extremely high levels of LDL cholesterol from birth, leading to early-onset cardiovascular disease . This condition is often caused by mutations in the LDL receptor gene (LDLR), which impairs the body's ability to remove LDL cholesterol from the blood. Patients with FH require lifelong LDL cholesterol-lowering treatments, including statins and other medications, to manage their cholesterol levels and reduce cardiovascular risk .
Statins are the first-line therapy for lowering LDL cholesterol and have been shown to significantly reduce the risk of coronary events. In patients with homozygous familial hypercholesterolemia, additional treatments such as mipomersen, an apolipoprotein B synthesis inhibitor, have been effective in further reducing LDL cholesterol levels.
Consuming dietary supplements like high-molecular-weight oat β-glucan (OBG) can also help reduce LDL cholesterol. A study demonstrated that a beverage containing 3 grams of OBG daily reduced LDL cholesterol by approximately 6% and decreased cardiovascular disease risk by about 8% in individuals with borderline high cholesterol.
High serum uric acid (SUA) levels have been identified as an independent risk factor for developing high LDL cholesterol and hypertriglyceridemia. A five-year cohort study in Japan found that elevated SUA levels significantly increased the risk of high LDL cholesterol in both men and women.
Individuals with metabolic syndrome often exhibit atherogenic dyslipidemia, characterized by high triglycerides and low high-density lipoprotein (HDL) cholesterol, alongside elevated LDL cholesterol. This combination significantly increases the risk of cardiovascular events . Managing these lipid abnormalities through lifestyle changes and medications is crucial for reducing cardiovascular risk.
High LDL cholesterol is a major risk factor for cardiovascular disease, influenced by dietary habits, genetic factors, and associated conditions like high serum uric acid and metabolic syndrome. Effective management includes dietary modifications, pharmacological interventions, and lifestyle changes to lower LDL cholesterol levels and mitigate cardiovascular risk. Understanding these factors and implementing appropriate strategies can significantly improve cardiovascular health outcomes.
Most relevant research papers on this topic